We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M Turnover 30.95%
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
-6.85%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$109M
AUM Growth
-$10.1M
Cap. Flow
+$2.31M
Cap. Flow %
2.12%
Top 10 Hldgs %
38.45%
Holding
73
New
4
Increased
25
Reduced
5
Closed
10
Avg Time Held
1.8 years
Top 10 Avg Time Held
1.4 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.88M
2
ARKO icon
ARKO Corp
ARKO
+$1.61M
3
BIDU icon
Baidu
BIDU
+$1.51M
4
THFF icon
First Financial Corp
THFF
+$955K
5
TALO icon
Talos Energy
TALO
+$935K

Top Sells

Rank Stock Value
1
AMSC icon
American Superconductor
AMSC
+$3.38M
2
RIGL icon
Rigel Pharmaceuticals
RIGL
+$2.96M
3
INCY icon
Incyte
INCY
+$1.71M
4
FHN icon
First Horizon
FHN
+$1.54M
5
TRC icon
Tejon Ranch
TRC
+$693K

Sector Composition

Rank Sector Weight
1 Healthcare 35.69%
2 Technology 11.09%
3 Materials 10.64%
4 Consumer Staples 8.17%
5 Consumer Discretionary 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CVS icon
26
CVS Health
CVS
$117B
$1.77M 1.63%
+30,000
New +$1.88M
2024 Q2
0 quarters
EOLS icon
27
Evolus
EOLS
$499M
$1.63M 1.49%
150,000
– –
2023 Q2
4 quarters
SABR icon
28
Sabre
SABR
$726M
$1.6M 1.47%
600,000
+100,000
+20% +$280K
2023 Q1
5 quarters
BRKL icon
29
DELISTED
Brookline Bancorp
BRKL
$1.59M 1.46%
190,000
+10,000
+6% +$87.8K
2022 Q4
6 quarters
SVC
30
Service Properties Trust
SVC
$824M
$1.54M 1.41%
60,000
– –
2021 Q3
11 quarters
PAAS icon
31
Pan American Silver
PAAS
$17.9B
$1.49M 1.37%
75,000
-25,000
-25% -$493K
2023 Q2
4 quarters
WBD icon
32
DELISTED
Warner Bros
WBD
$1.49M 1.37%
200,000
– –
2023 Q2
4 quarters
THFF icon
33
First Financial Corp
THFF
$880M
$1.48M 1.35%
40,000
+26,000
+186% +$955K
2024 Q1
1 quarter
PFE icon
34
Pfizer
PFE
$169B
$1.4M 1.28%
50,000
– –
2023 Q4
2 quarters
JAZZ icon
35
Jazz Pharmaceuticals
JAZZ
$14.1B
$1.33M 1.22%
12,500
– –
2024 Q1
1 quarter
XOMA icon
36
DELISTED
Xoma
XOMA
$1.3M 1.2%
55,000
– –
2023 Q4
2 quarters
DIT icon
37
AMCON Distributing
DIT
$58.6M
$1.15M 1.06%
12,300
+300
+3% +$31K
2020 Q4
14 quarters
NWL icon
38
Newell Brands
NWL
$2.45B
$1.12M 1.03%
175,000
– –
2023 Q4
2 quarters
HRTX icon
39
Heron Therapeutics
HRTX
$75M
$1.05M 0.96%
300,000
– –
2020 Q4
14 quarters
RVNC icon
40
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.03M 0.94%
400,000
+150,000
+60% +$512K
2023 Q4
2 quarters
COHU icon
41
Cohu
COHU
$2.57B
$993K 0.91%
+30,000
New +$931K
2024 Q2
0 quarters
NKTR icon
42
Nektar Therapeutics
NKTR
$1.3B
$930K 0.85%
50,000
-12,656
-20% -$267K
2020 Q4
14 quarters
AVIR icon
43
Atea Pharmaceuticals
AVIR
$379M
$894K 0.82%
270,000
– –
2021 Q2
12 quarters
HAS icon
44
Hasbro
HAS
$14.1B
$878K 0.81%
+15,000
New +$890K
2024 Q2
0 quarters
CRIS icon
45
Curis
CRIS
$1.48M
$828K 0.76%
6,000
– –
2022 Q4
6 quarters
KHC icon
46
The Kraft Heinz Company
KHC
$27.6B
$806K 0.74%
+25,000
New +$891K
2024 Q2
0 quarters
PK icon
47
Park Hotels & Resorts
PK
$3.15B
$749K 0.69%
50,000
– –
2023 Q1
5 quarters
ACAD icon
48
Acadia Pharmaceuticals
ACAD
$3.4B
$650K 0.6%
40,000
– –
2023 Q4
2 quarters
COYA icon
49
Coya Therapeutics
COYA
$104M
$606K 0.56%
100,000
– –
2023 Q2
4 quarters
CTSO icon
50
Cytosorbents Corp
CTSO
$9.36M
$598K 0.55%
42,500
+1,250
+3% +$21.7K
2021 Q1
13 quarters
1
2
3

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
TC
Town Capital Bel Air, Maryland $158M AUM

CM Management's Q2 2024 Portfolio in Review

As of Q2 2024, CM Management held 73 positions worth $109M, down 8.5% from $119M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

CM Management's Q2 2024 filing shows 4 new, 25 increased, 5 reduced and 10 closed positions. Its largest new stake was CVS Health: 30,000 shares worth $1.77M. The largest sale was American Superconductor, an estimated $3.38M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 43% a quarter earlier, followed by Technology and Materials.

  • CM Management's largest Q2 2024 buy was CVS Health: 30,000 shares worth $1.77M.
  • CM Management added most to ARKO Corp in Q2 2024, an estimated $1.61M increase.
  • CM Management's biggest Q2 2024 reduction was Pan American Silver, cutting an estimated $493K.
  • CM Management fully exited American Superconductor in Q2 2024, selling an estimated $3.38M.
  • CM Management's ten largest holdings make up 38% of its $109M portfolio in Q2 2024.
  • CM Management opened 4 new positions and closed 10 in Q2 2024.
  • CM Management's portfolio value fell 8.5% quarter-over-quarter to $109M.

Based on CM Management's 13F filing for Q2 2024, filed 1 Aug 2024.